Abacavir Sulphate Suppliers & Bulk Manufacturers
Available Forms: Tablet and Oral Solution
Available Strengths: Tab: 300 mg; oral solution: 20 mg/ml
Reference Brands: Ziagen®, Triumeq®(EU & US); Epzicom®(US), Kivexa®*(EU)
Category: Anti Viral
Abacavir Sulphate Tablets 300 mg are essential antiretrovirals for HIV-1 treatment. PharmaB2B connects buyers with certified global suppliers offering high-quality bulk Abacavir. Available as tablets and oral solution, ideal for compliant, large-scale procurement from WHO-GMP or USFDA-approved manufacturers.
Product Description:
Abacavir Sulphate Tablets are widely used in the treatment of HIV-1 infection, functioning as a nucleoside reverse transcriptase inhibitor (NRTI). Available in 300 mg tablets and pediatric oral solution (20 mg/mL), Abacavir is often combined with other antiretrovirals like Lamivudine and Dolutegravir. On PharmaB2B platforms, global buyers can connect with GMP-certified manufacturers and exporters offering high-quality Abacavir Sulphate for bulk supply. Ideal for procurement teams, distributors, and tender businesses seeking WHO-GMP or USFDA-approved sources, PharmaB2B simplifies compliant, cost-effective sourcing of essential antiretrovirals like Abacavir. Partner with trusted suppliers to support global access to HIV treatments.
Abacavir Sulphate — third party manufacturing & bulk supply
Abacavir Sulphate is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Abacavir Sulphate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Abacavir Sulphate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Abacavir sulphate is used to treat HIV-1 infection. It helps reduce viral load and improve immune function by inhibiting the HIV reverse transcriptase enzyme, and is always used as part of combination antiretroviral therapy.
It is made from the active nucleoside reverse transcriptase inhibitor (NRTI) compound abacavir sulphate, a synthetic carbocyclic nucleoside analogue.
The commonly known trade name is Ziagen.
Ziagen is manufactured by GlaxoSmithKline (GSK) and ViiV Healthcare. Several global generic manufacturers also produce abacavir sulphate tablets.
The generic name is abacavir sulphate.
The primary brand name is Ziagen.
It is manufactured in approved facilities in the UK, USA, Europe, and India, depending on the innovator or generic company supplying the product.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View DetailsLenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers